Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases have?
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases has 62 citations in the OpenAlex counts ScholarIQ stores.
When was Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases published?
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases has 2018 year in the ScholarIQ index.
What is the open-access status of Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases?
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases has gold oa status in the ScholarIQ index.
What is the DOI of Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases?
The DOI for Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases is on the source record.
What is the PMID of Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases?
The PMID for Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases is on the source record.
What is the OpenAlex record for Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases?
The OpenAlex for Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases is on the source record.